Low-expressing Breast Cancer

• CLINICAL_TRIALS trial_result · 2025-10-15
  Clinical Trial Update: HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada

  This clinical trial update reports real-world outcomes of trastuzumab deruxtecan (Enhertu) in Canadian patients with unresectable or metasta…

• CLINICAL_TRIALS trial_result · 2025-09-10
  Clinical Trial Update: PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer [NA]

  A clinical trial update indicates a study evaluating trastuzumab deruxtecan using PERCIST criteria for HER2-low metastatic breast cancer, wh…